Comparison of the Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

This study aims to evaluate whether a new eye treatment, called T2769, is as effective and safe as an existing treatment, Hylo-Forte®, for people suffering from moderate to severe dry eye syndrome. Dry eye syndrome is a common condition that can cause discomfort and vision problems. The study is important because finding a treatment that is as good as or better than current options could improve quality of life for many individuals experiencing this condition. Participants in the study will be using either T2769 or Hylo-Forte® to treat their eyes, and the effectiveness will be measured by looking at changes in the eye’s surface using a specific scale. This scale, known as the Oxford 0-15 scale, helps to assess how much the eye has improved over time. The study will compare the results from the beginning of the trial to the results observed on day 36. Since this is a late-stage study, it focuses on confirming the safety and performance of the T2769 treatment in a real-world setting.